Tag: Amgen Inc v. Sanofi

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Amgen Inc v. Sanofi

United States: Patent Litigation Update - January 2024 - Mondaq

Added to Collection on: 2024-02-14 20:39:10

Tags for this article:

Patent law
Amgen Inc v. Sanofi
Sufficiency of disclosure
Novelty and non-obviousness in Canadian patent law
U.S.C.
Amgen Inc.
Sanofi

Click the tags to see associated articles and topics

View Article Details
What is Next for Enablement and Written Description of Antibody Claims? - Patently-O

Added to Collection on: 2024-04-23 17:36:32

Tags for this article:

Monoclonal antibodies
Calcitonin gene-related peptide
Neuropeptides
Amgen Inc v. Sanofi
Teva Pharmaceuticals
Fremanezumab
Humanized antibody
Galcanezumab
Eli Lilly and Company
Monoclonal antibody therapy
Eli Lilly
Teva

Click the tags to see associated articles and topics

View Article Details
Enabling The "Full Scope" Of Claims In View Of The Supreme Court's Decision In Amgen

Added to Collection on: 2024-05-13 20:22:30

Tags for this article:

Amgen Inc v. Sanofi
Baxalta
Genentech
Amgen
Sufficiency of disclosure
Sanofi

Click the tags to see associated articles and topics

View Article Details
Please Don't Call Me a 'Genus': The High Bar for Section 112 in the Unpredictable Arts as ...

Added to Collection on: 2024-11-04 17:41:17

Tags for this article:

Patent law
Sufficiency of disclosure
Amgen
Patent claim
Eli Lilly and Company
Patent application
Ariad Pharmaceuticals, Inc. v. Eli Lilly & Co.
Amgen Inc v. Sanofi
United States

Click the tags to see associated articles and topics

View Article Details